logo
Plus   Neg
Share
Email

Fiat Chrysler Automobiles Posts Loss From Cont. Ops. In Q2; Net Revenues Down 56%

Fiat Chrysler Automobiles NV (FCAU) reported a second quarter loss from continuing operations of 1.05 billion euros compared to profit of 793 million euros, previous year. Loss per share from continuing operations was 0.66 euros compared to profit of 0.50 euros. Adjusted EBIT was negative at 928 million euros compared to profit of 1.53 billion euros. Adjusted loss per share was 0.65 euros compared to profit of 0.59 euros.

Second quarter IFRS net revenues were 11.71 billion euros, a decline of 56% from previous year. Worldwide combined shipments were 424 thousand units, down 63%, due to pandemic-related production stoppages and demand disruptions.

Available Liquidity was 17.5 billion euros at June 30, 2020, which excludes the 4.5 billion euros undrawn portion of the new 6.3 billion euros Intesa Sanpaolo facility entered into in June.

The company noted that its results and operating cash flows significantly improved in June.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Walt Disney World, the Orlando, Florida-based entertainment complex, is easing the health safety guidelines that were rolled out to prevent the spread of the ongoing COVID-19 pandemic. The complex is ending temperature checks in a phased manner following the advice of the Centers for Disease Control and Prevention (CDC) and local health officials. Frito-Lay North America, the convenient foods division of food and beverages giant PepsiCo, Inc., is recalling select Ruffles All Dressed Potato Chips citing the possible presence of undeclared milk ingredients, a known allergen, the U.S. Food and Drug Administration said. According to the agency, the recalled products may have distributed regionally to Walmart's Sam's Club Warehouses. Pfizer Inc. (PFE) and BioNTech SE (BNTX) announced Friday that they have initiated the Biologics License Application (BLA) process with the U.S. Food and Drug Administration (FDA) for approval of their mRNA vaccine to prevent COVID-19 in individuals 16 years of age and older. The companies initiated...
Follow RTT